Hundreds of Lawyers Gather at LexisNexis-Sponsored Symposium On Vioxx to Discuss Recent Developments in the Legal Drive Against Merck

January 11, 2005 09:15 AM US Eastern Timezone Hundreds of Lawyers Gather at LexisNexis-Sponsored Symposium On Vioxx to Discuss Recent Developments in the Legal Drive Against Merck for January 20-21 (Thursday-Friday) --(BUSINESS WIRE)--Members of the media are invited to attend: What: Vioxx Litigation Conference When: Thursday, January 20, 8 a.m. to 5 p.m. Friday, January 21, 8 a.m. to Noon Where: The Wyndham Philadelphia at Franklin Plaza Chaired by: Andy D. Birchfield, Jr. or Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., Montgomery, AL and Christopher A. Seeger of Seeger Weiss, LLP, New York. Topics on the agenda: -- The pharmacology of Vioxx(R) -- Cardiology issues associated with the use of Vioxx -- Legal perspective on science and clinical medical studies -- FDA legal and regulatory issues -- Theories of liability and defense including causation -- Expert witness issues including the type of experts needed to defend a case and how to prepare experts -- Status of litigation in state and federal courts -- Potential litigation beyond Vioxx To RSVP and obtain credentials for the Vioxx Litigation Conference, please contact Erin Bocherer at 614.825.1796 or erin.bocherer@fahlgren.com. Audio CDs of the conference are also available upon request. Note to Editors: Michael Leftkowitz, a LexisNexis analyst and editor of Mealey's Litigation Report: Arthritis Drugs, is available to comment on the following topics: -- Litigation related to Vioxx, including how litigation will proceed in the state and federal courts. -- Major drug product litigation in general as it relates to arthritis and diabetes drugs and vaccines. -- Historical background for existing mass torts involving Fen-Phen/Redux, Thimerosal and Propulsid, and other major drug brands. -- Mass drug tort reform in the United States. -- Impact of litigation on drug import laws in the United States. To schedule a briefing or obtain more biographical information on Leftkowitz, please contact Randy Dunham at (937) 865-8836 or mrandy.dunham@lexisnexis.com or Erin Bocherer at (614) 825-1796 or erin.bocherer@fahlgren.com.